Literature DB >> 17605759

Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia.

John Gardiner1, Deborah Barton, Jan Marc, Robyn Overall.   

Abstract

Familial dysautonomia (FD), a disease of the autonomic and sensory nervous systems, involves mutations in the protein IkappaB kinase complex-associated protein, which is a component of the human Elongator acetylase complex. We suggest a hypothesis in which defects in tubulin acetylation and impairment of microtubule-based protein trafficking may be an underlying cause of FD. In addition, an Arabidopsis homolog of the Elongator subunit ELP3 has been found to bind to the alphabeta-tubulin heterodimer, suggesting that alpha-tubulin may be a cytoplasmic target of Elongator acetylase activity. Studies of synergistic double mutants in yeast indicate a novel role for Elongator in cytoskeletal dynamics, although this is probably because of an effect on actin rather than microtubules. Finally, we suggest that tubulin deacetylase inhibitors may prove useful in the treatment of FD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605759     DOI: 10.1111/j.1600-0854.2007.00605.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  21 in total

1.  Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.

Authors:  Alan P Kozikowski; Sida Shen; Marta Pardo; Maurício T Tavares; Dora Szarics; Veronick Benoy; Chad A Zimprich; Zsófia Kutil; Guiping Zhang; Cyril Bařinka; Matthew B Robers; Ludo Van Den Bosch; James H Eubanks; Richard S Jope
Journal:  ACS Chem Neurosci       Date:  2018-12-14       Impact factor: 4.418

2.  dTip60 HAT activity controls synaptic bouton expansion at the Drosophila neuromuscular junction.

Authors:  Jessica Sarthi; Felice Elefant
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

3.  The histone acetyltransferase Elp3 plays in active role in the control of synaptic bouton expansion and sleep in Drosophila.

Authors:  Neetu Singh; Meridith T Lorbeck; Ashley Zervos; John Zimmerman; Felice Elefant
Journal:  J Neurochem       Date:  2010-08-24       Impact factor: 5.372

4.  Elongator protein 3 (Elp3) lysine acetyltransferase is a tail-anchored mitochondrial protein in Toxoplasma gondii.

Authors:  Krista L Stilger; William J Sullivan
Journal:  J Biol Chem       Date:  2013-07-22       Impact factor: 5.157

Review 5.  Animal and cellular models of familial dysautonomia.

Authors:  Frances Lefcort; Marc Mergy; Sarah B Ohlen; Yumi Ueki; Lynn George
Journal:  Clin Auton Res       Date:  2017-06-30       Impact factor: 4.435

6.  A coordinated codon-dependent regulation of translation by Elongator.

Authors:  Fanelie Bauer; Damien Hermand
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

7.  IKAP/Elp1 is required in vivo for neurogenesis and neuronal survival, but not for neural crest migration.

Authors:  Barbara J Hunnicutt; Marta Chaverra; Lynn George; Frances Lefcort
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

8.  Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.

Authors:  Lin Li; Katherine Gruner; Warren G Tourtellotte
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

9.  Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast.

Authors:  Assen Roguev; Sourav Bandyopadhyay; Martin Zofall; Ke Zhang; Tamas Fischer; Sean R Collins; Hongjing Qu; Michael Shales; Han-Oh Park; Jacqueline Hayles; Kwang-Lae Hoe; Dong-Uk Kim; Trey Ideker; Shiv I Grewal; Jonathan S Weissman; Nevan J Krogan
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

10.  Prognostic significance of elongator protein 3 expression in endometrioid adenocarcinoma.

Authors:  Yi Wang; Jun-Ichiro Ikeda; Nur Rahadiani; Suhana Mamat; Yutaka Ueda; Tian Tian; Takayuki Enomoto; Tadashi Kimura; Katsuyuki Aozasa; Eiichi Morii
Journal:  Oncol Lett       Date:  2011-09-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.